Bgm BGM
NASDAQ BGM
$0.28 -0.01 (-3.37%)
As of: Sep 9, 2026 · 11:54 AM EDT

Bgm (BGM) Shares Outstanding (2019 - 2026)

Bgm's (BGM) quarterly Shares Outstanding (Entity) came in at $113.3 million in Q3 2025, up 422.44% year-over-year from $21.7 million in Q3 2024, and up 422.44% quarter-over-quarter from $21.7 million in Q3 2024.

Analysis

Bgm (BGM) Shares Outstanding (2019 - 2026) Analysis & Trends

Bgm (BGM) has reported Shares Outstanding (Entity) for 7 consecutive years, with $113.3 million the latest figure, recorded in Q3 2025.

  • On a quarterly basis, Shares Outstanding (Entity) rose 422.44% year-over-year to $113.3 million in Q3 2025; TTM through Sep 2025 was $113.3 million, a 422.44% increase from a year earlier, with the FY2025 full-year figure at $113.3 million, up 422.44% from the prior year.
  • Shares Outstanding (Entity) was $113.3 million for Q3 2025 at Bgm, up from $21.7 million in the prior quarter.
  • Over five years, Shares Outstanding (Entity) peaked at $113.3 million in Q3 2025 and troughed at $7.2 million in Q3 2021.
  • A 5-year average of $34.2 million and a median of $21.7 million in 2023 frame the typical range for Shares Outstanding (Entity).
  • Across the five-year window, Shares Outstanding (Entity) changed 0.0% in 2022 and soared 422.44% in 2025, its largest moves.
  • Over 5 years, Shares Outstanding (Entity) stood at $7.2 million in 2021, then changed by 0.0% to $7.2 million in 2022, then jumped by 203.21% to $21.7 million in 2023, then changed by 0.0% to $21.7 million in 2024, then soared by 422.44% to $113.3 million in 2025.
  • The last three Shares Outstanding (Entity) figures came in at $113.3 million (Q3 2025), $21.7 million (Q3 2024), and $21.7 million (Q3 2023), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Teva Pharmaceutical Industries 42.61 Bn 38.95 Bn 2.15 Bn 1.17 Bn
2 Viatris 19.14 Bn 18.25 Bn 1.46 Bn 1.16 Bn
3 Dr Reddys Laboratories 9.85 Bn 9.68 Bn 396.53 Mn 832.44 Mn
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn 319.20 Mn
5 Bausch Health Companies 2.38 Bn 541.37 Mn 2.10 Bn 375.00 Mn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn 289.73 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn 21.16 Mn
8 Amphastar Pharmaceuticals 992.25 Mn 702.12 Mn 93.47 Mn 43.64 Mn
9 Fennec Pharmaceuticals 410.57 Mn 369.32 Mn 17.15 Mn 34.55 Mn
10 Bgm 31.79 Mn 20.27 Mn - 113.26 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 113.26 Mn
Sep 30, 2025 113.26 Mn
Mar 31, 2025 7.23 Mn
Sep 30, 2024 7.23 Mn
Mar 31, 2024 7.15 Mn
Sep 30, 2023 7.15 Mn
Mar 31, 2023 7.15 Mn
Sep 30, 2022 7.15 Mn
Mar 31, 2022 6.82 Mn
Sep 30, 2021 6.82 Mn
Mar 31, 2021 6.00 Mn
Sep 30, 2020 6.00 Mn
Sep 30, 2019 6.00 Mn